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INTRODUCTION
Ectopic pregnancy increases mortality and morbidity of
fertile women, accounting for 9% of all deaths during the
first trimester of pregnancy (1, 2). Moreover, the prevalence
of ectopic pregnancy is gradually increasing worldwide. In
northern Europe between 1976 and 1993, the incidence was
increased from 11.2 to 18.8 per 1,000 pregnancies (3). Total
admission to the hospital for ectopic pregnancy was increased
from 17,800 in 1970 to 88,400 in 1989, reaching 1 case per
60 pregnancies in the United States (4, 5). It was estimated
the incidence of ectopic pregnancy in Korea was 1 case per
20 to 26 pregnancies, which was relatively higher than in
Western countries (6, 7).
In the past, diagnosis of ectopic pregnancy based on clini-
cal findings such as vaginal bleeding and lower abdominal
pain imposed severe constraints on early detection, although
it has recently become possible to detect ectopic pregnancy
at an earlier stage by determination of serum human chori-
onic gonadotropin (hCG) levels and the use of advanced vagi-
nal ultrasonography techniques. In spite of this progress, both
hCG measurement and vaginal ultrasonography still have
limited effectiveness in diagnosing ectopic pregnancy at pri-
mary care centers due to inadequate accuracy and lack of cost-
effectiveness. Moreover, it is necessary to perform repeat quan-
tification of serum hCG levels when diagnostic results are
ambiguous, which may require additional time and costs.
Serum progesterone levels was suggested as a serum marker
for ectopic pregnancy, however some studies showed that
serum progesterone level is not effective and poor clinical
modality in the differential diagnosis of normal pregnancy,
ectopic pregnancy and spontaneous abortion (8, 9). Making
a quick and accurate diagnosis of ectopic pregnancy is desir-
able, but often difficult. Delayed diagnosis can cause rupture
of Fallopian tube, intra-abdominal hemorrhage, blood trans-
fusion and emergency laparotomy. Early diagnosis and inter-
vention either by medical or surgical treatment of ectopic
pregnancy can minimize its morbidity and mortality. Partic-
ularly, minimally invasive laparoscopic surgery at an early
stage can also promote conservation of a Fallopian tube and
increase future fertility.
Human chorionic gonadotropin is a glycoprotein with mo-
lecular weight of 37 kDa, that is synthesized by trophoblasts
during pregnancy; it consists of non-covalently bonded sub-
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Clinical Effectiveness of Urinary Human Chorionic Gonadotropin Related
Protein (hCGRP) Quantification for Diagnosis of Ectopic Pregnancy
We detected pregnancy related new molecule, human chorionic gonadotropin relat-
ed protein (hCGRP) in the urine of a pregnant women by using a monoclonal anti-
body against the human chorionic gonadotropin (hCG). This study examined the
effectiveness of urinary hCGRP quantification in diagnosing ectopic pregnancy. This
study included 40 normal pregnant women and 25 patients with ectopic pregnancy.
Patients’ serum and urinary intact whole hCG (i-hCG) and hCGRP concentrations
were measured using sandwich ELISA and the ratio of hCGRP to i-hCG was cal-
culated. Statistical analysis was performed using statistical package for social sci-
ences (SPSS) 10.0. Receiver operating characteristic (ROC) curve analysis was
performed to evaluate the cut-off value to discriminate ectopic pregnancies from
normal intrauterine pregnancies. Urinary hCGRP and hCGRP/i-hCG ratio in ectopic
pregnancy group (14±6.6 ng/mL, 4.6±1.9%, respectively) were significantly lower
than those of normal pregnancy group (149±10.2 ng/mL, 29.7±1.9%, respectively;
p<0.001). Based on ROC curve analysis, a cut-off point of urinary hCGRP/i-hCG
ratio <16.2% discriminated between ectopic pregnancy and normal pregnancy with
a sensitivity, specificity, positive predictive value and negative predictive value of
92.0%, 90.0%, 32.6%, and 99.5%, respectively. Urinary hCGRP/i-hCG ratio mea-
surement may be effective in diagnosing ectopic pregnancy. 
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units and . The secretion of hCG increases during the first
trimester in geometrical progression, reaching a maximum
at about 10 weeks of gestation. Thereafter, it decreases until
20 weeks of gestation and then is maintained at approximately
20% of the maximal level until late-stage gestation (10). Cur-
rently, it is a routine procedure to diagnose ectopic pregnancy
by a sensitive assay for hCG. It has also been reported that
ectopic pregnancy can be diagnosed by measurement of uri-
nary core fragment, a metabolic product of hCG (11).
We detected pregnancy related new molecule, human chori-
onic gonadotropin related protein (hCGRP) in the urine of
pregnant women by using a monoclonal antibody against the
hCG. In the preliminary study we found that monoclonal
antibody against hCGRP showed weaker reactivity in ectopic
pregnancy than normal pregnant women. This study was
conducted to examine the diagnostic usefulness of hCGRP
by a comparative analysis between hCGRP and intact whole
hCG (i-hCG) secretion for ectopic pregnancy. We evaluated
hCGRP secretion in normal pregnant women and ectopic
pregnancy patients using a sandwich ELISA employing two
monoclonal antibodies, HSM6042 and HSM6043, which
shows specific responsiveness to hCGRP rather than i-hCG.
MATERIALS AND METHODS
Patients
We enrolled patients from the outpatient clinics at the
Department of Obstetrics and Gynecology, Samsung Cheil
Hospital, Sungkyunkwan University School of Medicine;
Kangnam Cha Medical Center, Pochon University School of
Medicine and Kangsuh Mizmedi Hospital. Forty women with
normal pregnancies at 4 to 14 weeks amenorrhea, confirmed
on transvaginal ultrasonography, were assigned to the normal
pregnancy group. Twenty-five patients with ectopic pregnancy
diagnosed by laparoscopic surgery and confirmed by histologic
examination were assigned to the ectopic pregnancy group.
All patients were provided with the study details, including
objectives and methods, and all signed written consent forms
prior to enrollment in this study.
Among the patients whose intrauterine gestational sacs had
been detected on ultrasonography at prenatal or infertility
clinics, only those with a confirmation of fetal heart rate dur-
ing follow-up were included in the normal pregnancy group.
Patients who were confirmed as missed, incomplete or com-
plete abortion during follow-up examination were excluded.
Sample collection
The blood and urine were collected for the normal preg-
nancy group when the intrauterine gestational sac is initially
found through the transvaginal ultrasonography among the
patients visited prenatal or infertility clinics with 4 to 14
weeks amenorrhea. In case of chemical pregnancy, sampling
was withheld until confirmation of intrauterine gestational
sac. Gestational age and days after last menstrual period (LMP)
was estimated by gestational sac size with transvaginal ultra-
sonography. Mean days after LMP was 50.2±1.23 (mean±
SEM) days in normal pregnancy group. For the ectopic preg-
nancy group, blood and urine were collected at the time of
confirmation of ectopic pregnancy by laparoscopy. Gestational
age was estimated by last menstrual period. Mean days after
LMP was 48.6±1.65 (mean±SEM) days in ectopic pregnan-
cy group.
Serum and urine samples were stored at -20℃ for future
analysis.
Monoclonal antibody and hCG hormone
For the quantitative analysis of i-hCG and hCGRP, Humasis
Co. Ltd. (Gunpo, Korea) provided our group with four types
of mouse anti-hCG monoclonal antibody (HS 6301, HSM-
6238, HSM6042, HSM6043), as well as purified hCGRP.
Levels of i-hCG were analyzed according to the internation-
al criteria of the World Health Organization (WHO) (4th
IS, 75/589, NIBSC, U.K.).
HRP conjugation of monoclonal antibody
Two monoclonal antibodies, HS 6301 and HSM6043,
were conjugated to horseradish peroxidase (HRP) using EZ-
LINKTM Plus Activated Peroxidase kit (Pierce, Rockford, IL,
U.S.A.), to prepare the detection antibodies.
Sandwich ELISA
The concentration of i-hCG was measured using HSW6238
as the capture antibody and HRP-conjugated HS 6301 as
the detection antibody. HSW6238 was diluted to 10 g/mL
in coating buffer (0.1 M carbonate buffer, pH 9.5), and was
dispensed in 100- L aliquots in 96-well plates. HSW6238
was adsorbed at 4℃ for 24 hr and rinsed with a rinsing solu-
tion (0.05% Tween/PBS). Blocking solution (300 L; 0.2%
casein/PBS) was applied and reacted at room temperature for
3 hr, then rinsed to prepare the reaction plates. Samples and
hCG standards were added in 100- L aliquots and reacted
at 4℃ for 2 hr, then rinsed three times. HRP-conjugated
HS 6301 was dissolved in PBS to 10 g/mL and added in
100- L aliquots. After 2 hours at 4℃ the plates were rinsed
three times again. The development reagent of the HRP sub-
strate kit (Bio-Rad, Hercules, CA, U.S.A.) was added in 100-
L aliquots and reacted for 10 min. After 100 L of stopping
reagent (3% oxalic acid) was added to block the reaction, the
absorbance was measured with an automated ELISA reader
(Bio-Rad).
The concentration of hCGRP was measured using HSM-
6042 as the capture antibody and HRP-conjugated HSM6043
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as detection antibody, following the same basic method as
described above for the i-hCG ELISA. The concentration of
hCG and hCGRP was expressed in ng/ L. The intra-assay
coefficient of variation (CV) was 3.5%, the inter-assay CV was
8.9%, and the sensitivity was 2.0 ng/ L.
Statistical analysis
Statistical analysis was performed using statistical package
for social sciences (SPSS) 10.0. Independent sample t-test was
used to compare the differences between the groups. A receiver
operating characteristic (ROC) curve analysis was used to
estimate the predictive power of the measured variables, and
to determine the hCGRP/ihCG cut-off that optimally dis-
criminated ectopic pregnancy from normal intrauterine preg-
nancy.
The cut-off point was chosen to maximize sensitivity as well
as specificity. As a measure for the diagnostic ability of the
cut-off to predict ectopic pregnancy, the positive and negative
predictive values were determined at the calculated cut-off
value. The areas under the ROC curves (AUC) were calculated
by Analyte-it 1.69 program (Analyte-it software, Ltd.) to eval-
uate the discriminatory value of the test. Unless otherwise
stated, values are expressed as means±standard error of the
mean. Significance was defined as p-values less than 0.05.
RESULTS
Clinical characteristics of the groups are compared in Table
1. The subjects were similar with respect to mean age, gra-
vidity, parity and estimated days after LMP. Mean amenor-
rheic period at the time of confirmation was 50.2±1.23 days
in the normal pregnancy group and 48.6±1.65 days in the
ectopic pregnancy group. There was no significant difference
between the two groups (p=0.49).
The standardization of the sandwich ELISAs using two
different antibody combinations, HSW6238-HS 6301 and
HSM6042-HSM6043, demonstrated that specific binding
occurred, permitting quantification of hCG and hCGRP with
linear regression analysis R square value 0.956 and 0.995,
respectively (Fig. 1). 
Urinary i-hCG and hCGRP had clear distribution ranges
with small standard deviations that varied according to gesta-
tional week in both the normal and ectopic pregnancy groups.
Both i-hCG and hCGRP concentrations were significantly
lower in the ectopic pregnancy group compare to the nor-
mal pregnancy group, with a particularly marked decrease
in hCGRP levels (Fig. 2A, B, p<0.001).
In the normal pregnancy group, serum concentrations of
i-hCG and hCGRP varied widely, with significantly greater
standard deviations than the concentrations measured in urine.
However, in the ectopic pregnancy group, serum hCGRP
concentration was markedly decreased and had a small stan-
dard deviation, similar to that noted for urinary concentra-
tion (Fig. 2C, D, p<0.001). 
Urinary concentrations of i-hCG and hCGRP were 160±
27.4 ng/mL and 14±6.6 ng/mL, respectively, in the ectopic
pregnancy group, which were significantly lower than the
corresponding levels of i-hCG and hCGRP, 486±19.9 ng/
mL and 149±10.2 ng/mL respectively, in the normal preg-
nancy group (p<0.001). In particular, urinary hCGRP con-
centration during early ectopic pregnancy was about eleven
times lower than in the normal pregnancy group, although
urinary i-hCG was only three times lower than in the normal
pregnancy group. Thus the difference between the two groups
in hCGRP concentrations was significantly greater than the
difference in i-hCG concentrations. Consequently, the ratio
hCGRP/i-hCG was significantly lower in the ectopic preg-
Intrauterine 
pregnancy 
(n=40)
Ectopic 
Pregnancy
(n=25)
p-value*
Age (yrs) 29.4±0.43 29.8±0.75 NS (0.68)
Gravidity 2.1±0.20 1.9±0.17 NS (0.63)
Parity 0.3±0.09 0.3±0.07 NS (0.70)
Days after LMP 50.2±1.23 48.6±1.65 NS (0.49)
Serum Intact 1,018±50.3 350±59.4 <0.001
hCG (ng/mL)
Serum hCGRP (ng/mL) 468±51.6 35.9±17.5 <0.001
Serum hCGRP/i-hCG 42.2±4.2 9.5±4.0 <0.001
Ratio (%)
Urine Intact hCG (ng/mL) 486±19.9 160±27.4 <0.001
Urine hCGRP (ng/mL) 149±10.2 14.1±6.6 <0.001
Urine hCGRP/i-hCG 29.7±1.9 4.6±1.9 <0.001
Ratio (%)
Table 1. Descriptive statistics in intrauterine pregnancy and ec-
topic pregnancy group. Values are mean±SEM
NS, not significant; LMP, last menstrual period; hCG, human chorionic
gonadotropin; hCGRP, human chorionic gonadotropin related protein;
ihCG, intact whole human chorionic gonadotropin.
*Independent samples t-test
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Fig. 1. Specific reactivity of two anti-hCG monoclonal antibody
pairs (HS 6301/HSM6238, HSM6042/HSM6043) to intact hCG.
HS 6301/HSW6238
r2=0956
HSM6042/HSM6043
r2=0.995
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nancy group, with a value of 4.6±1.9%, than in the normal
pregnancy group, which had a ratio of 29.7±1.9% (Table 1,
Fig. 3, p<0.001).
To determine the clinical significance of these statistical
findings, a ROC curve was derived (Fig. 4). The AUC (±SE)
for the ROC curves for serum hCGRP/ihCG ratio and urinary
hCGRP/ihCG ratio were 0.832±0.054 and 0.916±0.042,
respectively. This value represents the overall probability (91.6
%) that ectopic pregnancy can be correctly identified by uri-
nary hCGRP/ihCG ratio measurement. By analyzing the ROC
Fig. 3. Mean hCGRP/i-hCG ratios and 95% confidence intervals in intrauterine pregnancy and ectopic pregnancy group. (A) Urine samples,
(B) Serum samples. IUP, intrauterine pregnancy; EP, ectopic pregnancy.
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Fig. 2. Distribution of i-hCG and hCGRP concentration in intrauterine pregnancy and ectopic pregnancy. (A) Urine of intrauterine pregnancy,
(B) Urine of ectopic pregnancy, (C) Serum of intrauterine pregnancy, (D) Serum of ectopic pregnancy.
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curve the cut-off value giving optimal discriminatory hCGRP/
ihCG ratio were found to be 16.2% in urine and 9% in serum
which sensitivity and specificity for diagnosis of ectopic preg-
nancy was of 80%, 85% in serum and 92%, 90% in urine
respectively (Table 2).
DISCUSSION
Early diagnosis of an unruptured ectopic pregnancy is essen-
tial to diminish mortality and morbidity, and for the preser-
vation of oviducts in patients with ectopic pregnancy. Patients
with ectopic pregnancy may manifest lower abdominal pain
and vaginal bleeding as abnormal clinical findings during
early-stage pregnancy. Ectopic pregnancy can not be diagnosed
solely on the basis of these clinical symptoms. Additional
studies are necessary to make a proper diagnosis of an ectopic
pregnancy prior to initiation of either medical or surgical
intervention. Clinical examination, transvaginal ultrasonog-
raphy, quantification of serum gonadotropin and progesterone
are currently utilized as its diagnostic modalities, however no
single test is performed satisfactorily thus far (8, 12, 13).
In their evaluation of diagnostic methods for ectopic preg-
nancy, Gracia et al. reported that vaginal ultrasonography and
gonadotropin quantification gave the most satisfactory results,
although they concluded that new diagnostic methods for
ectopic pregnancy were required since it requires an average
of 36 hr to diagnose ectopic pregnancy, not to mention the
resources devoted to collecting blood samples from more than
half of all obstetric patients (14). 
Gonadotropin consists of two non-covalently bonded sub-
units and and is released by trophoblasts during preg-
nancy. Subunit (92 amino acids) is similar to the glycopro-
tein hormones secreted by the pituitary gland, including fol-
licle stimulating hormone (FSH), thyroid stimulating hor-
mone (TSH) and luteinizing hormone (LH). Unlike the other
glycoprotein hormones, subunit (145 amino acids) has dis-
tinct traits. From an early stage of pregnancy, hCG is released
in the biochemically active form in geometrical progression,
reaching maximum levels at about 10 weeks of gestation,
decreasing between 10 to 16 weeks of gestation, and then
the level is maintained approximately one-fifth of the prior
maximum. Gonadotropin released by trophoblasts has higher
activity, higher molecular weight and more negative charge
during the first trimester compared to that released during
late-stage pregnancy; gonadotropin has more significant bio-
chemical activity than immune activity during the first tri-
mester (15-17). Moreover, transformation of gonadotropin
isoforms, in addition to acidity changes, occurs at about 13
weeks of gestation (18).
Apparently, the hCG level is not proportional to ovarian
hormone levels in all patients, playing an important role in
salvaging luteinizing hormone and maintaining estrogen and
progesterone during early pregnancy. Recent studies showed
that the serum levels of estradiol and progesterone were lower
in patients with ectopic pregnancy than in normal pregnant
women (19-21). Moreover, it is inferred that luteal dysfunc-
tion is not due to ectopic pregnancy per se, but rather to de-
rangement of trophoblastic division, since gonadotropins
secreted by trophoblastic tissues from ectopic pregnancy as
well as intrauterine pregnancy have equivalent immune and
biochemical activities (22, 23).
Multiple hCG related molecules are present in serum and
urine during pregnancy (10). These include degraded hCG
molecules, hyper- and hypoglycosylated hCG, free subunits,
large free subunits, fragments. Several antibody combinations
are used to measure hCG concentration. Some of these anti-
body combinations may detect only intact hCG molecules.
Some require the C-terminal segment of the -subunit to
be intact and some detect nonnicked molecules and free -
subunit. 
Cole et al. reported that the level of -core fragment (M.W.=
9000) was decreased in patients with ectopic pregnancy or
spontaneous abortion as compared to normal pregnant women,
showing a divergent pattern of secretion as gestation progresses.
Moreover, they reported that spontaneous abortion (66%)
and ectopic pregnancy (92%) could be diagnosed through use
of a discrimination curve, with a false-positive rate of 4% (11,
24). Borrelli et al. reported that concentrations of all forms
Urinary hCGRP for Diagnosis of Ectopic Pregnancy 465
Se
ns
itiv
ity
1.0
0.8
0.6
0.4
0.2
0.0
0.0 0.2 0.4 0.6 0.8 1.0
1-Specificity
Fig. 4. Receiver operating characteristic (ROC) curve plotting sen-
sitivity and false positive rate and the optimal discriminatory ihCG/
hCGRP ratio cut-off point in serum (filled circle) and urine (filled
square). ihCG, intact human chorionic gonadotropin; hCGRP,
human chorionic gonadotropin related protein.
Serum
Urine
Cut-off point
(hCGRP/ihCG=0.09)
Cut-off point
(hCGRP/ihCG=0.162)
CI, confidence interval.
Serum (n=65) Urine (n=65)
Sensitivity (%) (95% CI) 80.0 (59.3-93.2) 92.0 (74.0-99.0)
Specificity (%) (95% CI) 85.0 (70.2-94.3) 90.0 (76.3-97.2)
Positive predictive value (%) 21.9 32.6 
Negative predictive value (%) 98.9 99.5
Table 2. Diagnosis of ectopic pregnancy using hCGRP/i-hCG
ratio
of hCG were lower in cases of ectopic pregnancy and spon-
taneous miscarriage than in viable pregnancies and measure-
ment of hCG isoform had 100% sensitivity at a specifici-
ty of 79% for detection of ectopic pregnancy (25).
We detected pregnancy related new molecule, hCGRP in
the urine of a pregnant women by using a monoclonal anti-
body against the hCG and confirmed that hCGRP was dif-
ferent from previously known multiple hCG related molecules
including subunit, subunit, -core fragment and hyper-
glycosylated hCG. We detected separate band of hCGRP from
other known molecules using Western blot analysis of the
hCG standard probed with mouse anti hCG monoclonal anti-
bodies HSM6043 and HSM6042. The hCGRP is thought
to be easily degraded at room temperature and shows weak
immunoreactivity to common antibody combination. We
believe these are the reasons why it is difficult to separate
hCGRP from other known molecules.
It is assumed that hCGRP is one of several metabolic prod-
ucts synthesized by trophoblasts from i-hCG during preg-
nancy. In their study of hCG metabolic products, Cole et al.
noted that various metabolic products such as nicked hCG,
hyper- and hypo-glycosylated hCG, hCG missing the C-termi-
nal extension, free , free , nicked free and -core frag-
ment are synthesized from i-hCG; inactive forms of gonado-
tropin, namely nicked hCG, free and -core fragment, are
elevated in patients with Down’s syndrome and gestational
trophoblastic disease. The authors postulated that the above
findings are due to activation of metabolic pathways degrad-
ing active forms of gonadotropin, as well as activity of placen-
tal nicking enzymes (24).
The combination of monoclonal antibodies HSM6043 and
HSM6042 in a sandwich ELISA had markedly low reactivity
to i-hCG and highly specific reactivity to the hCG isoform,
hCGRP (Fig. 1, R2=0.995). Moreover, we confirmed that the
above antibody combination reacted to different hCG isoforms,
other than the urinary -core fragment from the study by
Cole et al. on the basis of the finding that this antibody com-
bination reacted to serum hCG isoforms, in addition to iso-
forms present in the urine of pregnant women.
Another combination of monoclonal antibodies, namely
HSM6031 and HSM6238, specifically captures and detects
i-hCG. Analysis of the secretion of i-hCG and hCGRP in
both groups, using the two different combinations of mono-
clonal antibodies, showed that i-hCG secretion was signifi-
cantly decreased in ectopic pregnancy, a finding consistent
with previous studies.
We confirmed that it is more effective to analyze hCGRP/
i-hCG ratio, instead of measuring i-hCG or hCGRP levels
alone, as a basis for diagnosis of ectopic pregnancy, since i-hCG
levels show dilutional variation among individuals, even at
the same period of gestation. Use of the ratio is especially
advantageous in minimizing analytical errors without adjust-
ment with urinary creatinine.
In this study, the results indicated that the level of i-hCG
was decreased and the rate of hCG isoform degradation was
increased in patients with ectopic pregnancy. It is likely that
the secretion of i-hCG itself was decreased due to derangement
of trophoblastic division in patients with ectopic pregnancy.
Moreover, hCGRP may have a molecular structure that is
more easily degraded by nicking or degradation enzymes in
patients with ectopic pregnancy than in normal pregnant
women; it is likewise possible that hCGRP, an intermediate
of i-hCG, may be degraded quickly due to increased activity
of degradation enzymes.
The ELISAs for determination of urine i-hCG levels and
hCGRP/i-hCG, using monoclonal antibodies that specifically
recognize the structural changes of hCG isoforms and degra-
dation products, offer better diagnostic outcomes than hCG
quantification combined with ultrasonography (80% sensi-
tivity) which is currently known as the best diagnostic method
for ectopic pregnancy (13). It is also of great advantage to
have a diagnostic method that is cost-effective and indepen-
dent of the experience of sonography technicians. In cases
where the hCGRP/i-hCG ratio fall under the cut-off values,
the time required to make a diagnosis of ectopic pregnancy
is relatively short as compared to conventional diagnostic
methods and it does not require repeated testing.
These studies are preliminary limited to 25 ectopic and
40 normal pregnancies. The number of patients studied was
relatively small to make any conclusion. The bias may exist
due to exclusion of missed, incomplete or complete abortion.
Further prospective studies should be conducted on large
patient populations including miscarriage group to determine
the clinical effectiveness of hCGRP/i-hCG measurement for
diagnosis of patients with ectopic pregnancy and to elucidate
more precisely the structure and physiological function of
hCGRP.
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